• About us
• Contact

Advertisement

Financing › Details

Mission Therapeutics–Roche: investment, 201311 financing round Series B totalling £20m incl existing investor Roche Venture Fund

 

	Period	2013-11-18
	Money taker	Roche Venture Fund (RVF)
	Group	Roche (Group)
	Product	cancer drug
	Product 2	venture capital

Record changed: 2025-03-16

Advertisement

More documents for Mission Therapeutics Ltd.

• [1] Mission Therapeutics Ltd.. (3/14/24). "Press Release: Mission Therapeutics Raises £25.2 Million to Progress Clinical Candidates in the Area of Mitophagy". Cambridge....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.